Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
PHASE4
This study is researching a drug called dupilumab. The study is focused on ...
A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
PHASE3
Atopic dermatitis (AD) is a skin condition that may cause a rash and itchin...
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
PHASE3
Atopic dermatitis (AD) is a skin condition that may cause a rash and itchin...
Status
Recruiting
Location
Applied Research Center and Wellness Clinic /ID# 268547